Researchers are exploring the use of gene prioritization to identify potential drug targets for schizophrenia. This approach involves analyzing genetic data and using techniques such as artificial intelligence and multi-omics to prioritize genes that may be associated with the disorder. Studies are being conducted to develop and refine methods for identifying these targets, with the goal of advancing precision drug discovery and potential clinical applications.